Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (TCTR20250805002) titled 'Testing Probiotic Supplements for Improving Metabolism and Liver Health in People with Obesity' on Aug. 5.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Thailand Institute of Scientific and Technological Research (TISTR)
Condition:
Participants must present at least two of the following metabolic risk factors: elevated triglycerides (more than 150 mg/dL), low HDL cholesterol (less than 40 mg/dL for men or less than 50 mg/dL for women), high blood pressure (more than 130/85 mmHg or on antihypertensive medication), or elevated fasting glucose (more than 100 mg/dL or on antidiabetic treatm...